...
CILARGE

Cigna Corporation

HealthcareMedical - Healthcare Plans
$289.82
$0.01(+0.35%)
52W$239.51
$350.00
FinancialsValuationvs UNH
Updated Mar 2, 12:00 AM
RSI55
RS Rating44/99
Beta0.19
Volatility33%
F-Score6/9
Mkt Cap$76.4B
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Cigna Corporation is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 44), showing significant lag compared to the market leaders. Earnings growth of 165% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.

Relative Strength
44
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
0.19
vs S&P 500
LOW VOL
52W Position
46%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$279.79
50 SMA > 100 SMA$279.85
100 SMA > 150 SMA$284.05
150 SMA > 200 SMA$291.13

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$285.17+1.63%ABOVE
50 SMA$279.79+3.59%ABOVE
100 SMA$279.85+3.56%ABOVE
150 SMA$284.05+2.03%ABOVE
200 SMA$291.13-0.45%BELOW

Price Performance

1D+0.3%
1W+2.3%
1M+6.4%
3M+4.5%
6M-3.1%
YTD+3.8%
1Y-6.2%
3Y-0.3%
52-Week Trading Range46% from low
$289.82
52W Low$239.51
52W High$350.00

Technical Indicators

RSI (14)NEUTRAL
55.1
305070
VCP ScoreWARM
7/10
Base depth: 13.6%

Risk Profile

Beta
0.19
52W Vol
33%
ATR
$7.64
Max DD (1Y)
-28%

Volume Analysis

Today
289
50D Avg
1.33M
Vol Ratio
0.00x
Liquidity
LIQUID

Earnings Momentum

Q4'24+47%
$5.13
Q1'25+600%
$4.85
Q2'25+5%
$5.71
Q3'25+165%
$6.97
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+21.62%
5 Years:+9.98%
3 Years:+12.39%
TTM:+15.28%

Compounded Profit Growth

10 Years:+4.47%
5 Years:-2.05%
3 Years:-8.36%
TTM:+113.77%

Stock Price CAGR

10 Years:+7.58%
5 Years:+6.16%
3 Years:-0.26%
1 Year:-6.16%

Return on Equity

10Y Avg:13.3%
5Y Avg:12.5%
3Y Avg:11.2%
Last Year:14.6%

Key Metrics

Market Cap$76.4B
Gross Margin10.5%
Net Margin1.4%
Piotroski F-Score6/9

More CI Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

CI vs UNHUNHCVS

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 44 meansCI outperformed 44% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.19 means 81% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 6/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 7/10 with WARM status.

Frequently Asked Questions

Is CI in an uptrend right now?

CI has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is CI overbought or oversold?

CI's RSI (14) is 55. The stock is in neutral territory, neither overbought nor oversold.

Is CI outperforming the market?

CI has a Relative Strength (RS) Rating of 44 out of 99. CI is currently lagging the broader market.

Where is CI in its 52-week range?

CI is trading at $289.82, which is 83% of its 52-week high ($350.00) and 46% above its 52-week low ($239.51).

How volatile is CI?

CI has a Beta of 0.19 and 52-week volatility of 33%. It's less volatile than the S&P 500 - generally more stable.